Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine. (Q36220618)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Rebecca C Auer

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

20

John C Bell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

13

Fabrice Le Boeuf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

16

David F Stojdl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

17

Brian D Lichty

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1

Chantal G Lemay

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Julia L Rintoul

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Agnieszka Kus

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Jennifer M Paterson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Vanessa Garcia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Lisa Ferreira

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Byram W Bridle

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

David P Conrad

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Vera A Tang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Jean-Simon Diallo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Rozanne Arulanandam

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kenneth Garson

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Barbara C Vanderhyden

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Harold L Atkins

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kelley A Parato

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

3 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1791-1799

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

6 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Exploiting the mutanome for tumor vaccination.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Thunder and lightning: immunotherapy and oncolytic viruses collide

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Suppression of T-cell responses by tumor metabolites

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Innate or adaptive immunity? The example of natural killer cells

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

1 October 2017

Melanoma Immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Potentiating cancer immunotherapy using an oncolytic virus

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Tumor infection by oncolytic reovirus primes adaptive antitumor immunity

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

How tumours escape mass destruction

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Use of biological therapy to enhance both virotherapy and adoptive T-cell therapy for cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Combining radiotherapy and immunotherapy: a revived partnership

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

New aspects of natural-killer-cell surveillance and therapy of cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Attenuated vesicular stomatitis viruses as vaccine vectors

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic mice

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Postoperative active specific immunization in colorectal cancer patients with virus-modified autologous tumor-cell vaccine. First clinical results with tumor-cell vaccines modified with live but avirulent Newcastle disease virus

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

In vitro and clinical characterisation of a newcastle disease virus-modified autologous tumour cell vaccine for treatment of colorectal cancer patients

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

A ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Expression of CD69 on T-cell subsets in HIV-1 disease.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3437573

Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens

5 December 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/22760544

12 December 2020

Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22760544

12 December 2020

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/22760544

12 December 2020

Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22760544

12 December 2020

Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming

1 reference

https://pubmed.ncbi.nlm.nih.gov/22760544

12 December 2020

CD69 expression as an index of T-cell function: assay standardization, validation and use in monitoring immune recovery

1 reference

https://pubmed.ncbi.nlm.nih.gov/22760544

12 December 2020

Detection of intracellular cytokines by flow cytometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/22760544

12 December 2020

Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22760544

12 December 2020

Reovirus Virotherapy Overrides Tumor Antigen Presentation Evasion and Promotes Protective Antitumor Immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22760544

12 December 2020

Identifiers

DOI

10.1038/MT.2012.128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PubMed publication ID

22760544

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22760544%20AND%20SRC:MED&resulttype=core&format=json